Thirumurthi S, Desilva R, Castillo D L, Richardson P, Abraham N S
Houston Center for Quality of Care & Utilization Studies, Section of Health Services Research, Michael E. DeBakey VA Medical Center, Houston, TX 77030, USA.
Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1309-16. doi: 10.1111/j.1365-2036.2008.03845.x. Epub 2008 Aug 30.
Helicobacter pylori is a prevalent organism implicated in peptic ulcer disease.
To validate administrative data for diagnosis of H. pylori-infected patients.
Administrative data identified patients with ICD-9 code for H. pylori (041.86) or prescription of eradication therapy; diagnosis was confirmed by chart abstraction. Multivariable regression assessed predictors of infection considering drug therapy, ICD-9 code 041.86, procedure code, in-patient or out-patient diagnostic code, age, gender and race to generate an algorithm for validation.
The test cohort of 531 patients (361 potential cases; 170 random controls) was primarily male (94%), Caucasian (59%) and elderly [67 years (s.d. 10)]. The positive predictive value (PPV) of ICD-9 code 041.86 was 100% and 97.4% if from an in-patient or out-patient encounter, respectively. Eradication drug therapy had a PPV of 73.7% (triple therapy) and 97.7% (quadruple therapy). The strongest predictors were out-patient ICD-9 code 041.86 (OR 8.1; 95% CI: 7.0-9.1); eradication drug therapy (OR 7.4; 95% CI: 6.6-8.3); oesophagogastroduodenoscopy (OR 3.5; 95% CI: 3.3-3.6); and age > or =70 (OR 1.2; 95% CI: 1.1-1.4). An algorithm including these data elements yielded a c-statistic of 0.93 and PPV of 97.9%.
Administrative data can diagnose H. pylori-infected patients. The diagnostic algorithm includes presence of eradication drug therapy overlapping with an out-patient ICD-9 code 041.86 among elderly adults.
幽门螺杆菌是一种与消化性溃疡疾病相关的常见病原体。
验证用于诊断幽门螺杆菌感染患者的管理数据。
管理数据识别出具有幽门螺杆菌ICD - 9编码(041.86)或根除治疗处方的患者;通过病历摘要确认诊断。多变量回归分析在考虑药物治疗、ICD - 9编码041.86、手术编码、住院或门诊诊断编码、年龄、性别和种族的情况下评估感染的预测因素,以生成验证算法。
531例患者的测试队列(361例潜在病例;170例随机对照)主要为男性(94%)、白种人(59%)且年龄较大[67岁(标准差10)]。ICD - 9编码041.86的阳性预测值(PPV),如果来自住院或门诊就诊,分别为100%和97.4%。根除药物治疗的PPV为73.7%(三联疗法)和97.7%(四联疗法)。最强的预测因素为门诊ICD - 9编码041.86(比值比8.1;95%置信区间:7.0 - 9.1);根除药物治疗(比值比7.4;95%置信区间:6.6 - 8.3);食管胃十二指肠镜检查(比值比3.5;95%置信区间:3.3 - 3.6);以及年龄≥70岁(比值比1.2;95%置信区间:1.1 - 1.4)。包含这些数据元素的算法得出的c统计量为0.93,PPV为97.9%。
管理数据可用于诊断幽门螺杆菌感染患者。诊断算法包括在老年人中存在与门诊ICD - 9编码041.86重叠的根除药物治疗。